WHO ICTRP trial
Clinical Study of Thalidomide for Night Sweats in Pancreatic Cancer Patients…
ChiCTR2500111827 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500111827 |
|---|---|
| Public title | Clinical Study of Thalidomide for Night Sweats in Pancreatic Cancer Patients Receiving Chemotherapy |
| Scientific title | Clinical Study of Thalidomide for Night Sweats in Pancreatic Cancer Patients Receiving Chemotherapy |
| Primary sponsor | Nanjing BenQ Mecical Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Night sweats |
| Interventions | Experimental group:Take 100mg of thalidomide orally every night before bedtime. |
| Registration date | Nov 6, 2025 |
| Target size | Experimental group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: